Comparison of Approaches for Estimating Incidence Costs of Care for Colorectal Cancer Patients

BACKGROUND: Estimates of the costs of medical care vary across patient populations, data sources, and methods. The objective of this study was to compare 3 approaches for estimating the incidence costs of colorectal cancer (CRC) care using similar patient populations, but different data sources and methods. METHODS: We used 2 data sources, linked SEER-Medicare and Medicare claims alone, to identify newly diagnosed CRC patients aged 65 and older and estimated their healthcare costs during the observation period, 1998 to 2002. Controls were matched by sex, age-group, and geographic location. We compared mean net costs, measured as the difference in total cost between cases and controls, for: (1) a SEER-Medicare cohort, (2) a Medicare claims alone cohort, and (3) a modeled phase of care approach using linked SEER-Medicare data. The SEER-Medicare cohort approach was considered the reference. RESULTS: We found considerable variability across approaches for estimating net costs of care in CRC patients. In the first year after diagnosis, mean net costs were $32,648 (95% CI: $31,826 and $33,470) in the SEER-Medicare cohort. The other approaches understated mean net costs in year 1 by about 16%. Mean net 5-year costs of care were $37,227 (95% CI: $35,711 and $38,744) in the SEER-Medicare cohort, and $30,310 (95% CI: $25,894 and $34,726) in the claims only approach, with the largest difference in the 65 to 69 age group. Mean net 5-year costs of care were more similar to the reference in the modeled phase of care approach ($37,701 [range: $36,972 and $38,446]). Differences from the SEER-Medicare cohort estimates reflect misclassification of prevalent cancer patients as newly diagnosed patients in the Medicare claims only approach, and differences in years of data and assumptions about comparison groups in the modeled phase of care approach. CONCLUSIONS: CRC incidence cost estimates vary substantially depending on the strategy and data source for identifying newly diagnosed cancer patients and methods for estimating longitudinal costs. Our findings may inform estimation of costs for other cancers as well as other diseases

Cancer · Cohort · Cohort study · Colorectal cancer · Health care · Incidence (geometry) · Demography · Economic and Financial Impacts of Cancer · Global Cancer Incidence and Screening · Internal Medicine · Medicine · Primary Care and Health Outcomes

• Comparison of Approaches for Estimating Prevalence Costs of Care for Cancer Patients

  K Robin Yabroff, Joan L Warren et al.•Medical Care•2009

  Incluir item

• Projections of the Cost of Cancer Care in the United States

  Angela B Mariotto, K Robin Yabroff et al.•CancerSpectrum Knowledge…•2011

  Incluir item

• Health care costs of breast, prostate, colorectal and lung cancer care by clinical stage and cost component

  Open Access•Oliver Ibarrondo, Garbiñe Lizeaga et al.•Gaceta Sanitaria•2022

  Incluir item

• Cost Comparisons and Methodological Heterogeneity in Cost-of-illness Studies

  Alan J Ó Céilleachair, Paul Hanly et al.•Medical Care•2013

  Incluir item

• When Does an Episode of Care for Cancer Begin

  Mark C Hornbrook, 一郎 岩本 et al.•Medical Care•2013

  Incluir item

• Health Care Costing

  Joseph Lipscomb, K Robin Yabroff et al.•Medical Care•2009

  Incluir item

• Advancing the Science of Health Care Costing

  Joseph Lipscomb, Paul G Barnett et al.•Medical Care•2009

  Incluir item

• Inventory of Data Sources for Estimating Health Care Costs in the United States

  Jennifer L Lund, K Robin Yabroff et al.•Medical Care•2009

  Incluir item

• Overview of Methods to Estimate the Medical Costs of Cancer

  William E Barlow•Medical Care•2009

  Incluir item

• A importância dos métodos de custeio e valoração nas avaliações econômicas em saúde

  Open Access•Alexander Itria, H Maria Dutilh Novaes et al.•Physis Revista de Saúde Coletiva•2012

  Incluir item

• Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees

  Gerald F Riley, Arnold L Potosky et al.•American Journal of Public Health•1994

  Incluir item

• Comparison of Approaches for Estimating Prevalence Costs of Care for Cancer Patients

  K Robin Yabroff, Joan L Warren et al.•Medical Care•2009

  Incluir item

• Obtaining Long-Term Disease Specific Costs of Care

  Martin L Brown, Gerald F Riley et al.•Medical Care•1999

  Incluir item

• Use of Medicare Hospital and Physician Data to Assess Breast Cancer Incidence

  Joan L Warren, Eric J Feuer et al.•Medical Care•1999

  Incluir item

• Health Limitations and Quality of Life Associated With Cancer and Other Chronic Diseases by Phase of Care

  K Robin Yabroff, Timothy S Mcneel et al.•Medical Care•2007

  Incluir item

• Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis

  Gerald F Riley, Roberto Montagna et al.•Medical Care•1995

  Incluir item

• Estimating Health Care Costs Related to Cancer Treatment From Seer-Medicare Data

  Martin L Brown, Gerald F Riley et al.•Medical Care•2002

  Incluir item

• The Sensitivity of Medicare Claims Data for Case Ascertainment of Six Common Cancers

  Gregory S Cooper, Zhong Yuan et al.•Medical Care•1999

  Incluir item